NCT05596344

Brief Summary

This study was a single-center prospective, real-world observational study with plans to enroll all eligible patients. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
80mo left

Started May 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
May 2023Nov 2032

First Submitted

Initial submission to the registry

October 24, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 27, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

May 20, 2023

Completed
9.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2032

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2032

Last Updated

November 13, 2023

Status Verified

October 1, 2023

Enrollment Period

9.5 years

First QC Date

October 24, 2022

Last Update Submit

November 10, 2023

Conditions

Malignant TumorAnxietyDepression

Outcome Measures

Primary Outcomes (6)

  • Hospital Anxiety Depression Scale

    Confirmed in 1 day

    Confirmed in 1 day

  • Hospital Anxiety Depression Scale

    End of the treatment

    End of the treatment

  • Hospital Anxiety Depression Scale

    The treatment ended 3 months later

    The treatment ended 3 months later

  • Hospital Anxiety Depression Scale

    The treatment ended 6 months later

    The treatment ended 6 months later

  • Hospital Anxiety Depression Scale

    The treatment ended one year later

    The treatment ended one year later

  • Hospital Anxiety Depression Scale

    The treatment ended 2 years ago

    The treatment ended 2 years ago

Interventions

Hospital Anxiety and Depression ScaleOTHER

The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with malignant tumors diagnosed by pathology receiving inpatient treatment in Henan Cancer Hospital.

You may qualify if:

  • Men and women of all ages are welcome.
  • Pathological diagnosis of malignant tumor in our hospital.
  • Received at least one hospitalization at this hospital.
  • The expected survival time is greater than 1 year.

You may not qualify if:

  • There was no pathological report of malignancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Bone and Soft Tissue ,Henan Cancer Hospital

Zhengzhou, Henan, 450008, China

RECRUITING

MeSH Terms

Conditions

NeoplasmsAnxiety DisordersDepression

Interventions

4-amino-4'-hydroxylaminodiphenylsulfone

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Central Study Contacts

Wang Jiaqiang, Dr

CONTACT

13592413731wjqwtj@126.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate chief physician

Study Record Dates

First Submitted

October 24, 2022

First Posted

October 27, 2022

Study Start

May 20, 2023

Primary Completion (Estimated)

November 30, 2032

Study Completion (Estimated)

November 30, 2032

Last Updated

November 13, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations

CN(1)